Navigation Links
DuPont, Dow AgroSciences Agree to Cross License Next-Generation Soybean Herbicide Tolerant Traits
Date:11/12/2009

New Traits Enable Farmers to Use More Effective Weed Control Solutions

Wilmington, DE and Indianapolis, IN (Vocus) November 12, 2009 -- DuPont and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: Dow), announced they have entered into a commercial cross-licensing agreement that will enable the two companies to deliver expanded herbicide-tolerant soybean options to farmers in the next decade.

Under the agreement, Dow AgroSciences is licensing non-exclusively its proprietary herbicide tolerant trait technology for soybeans to DuPont business Pioneer Hi-Bred. In addition, Pioneer is licensing non-exclusively its proprietary Optimum® GAT® trait for soybeans to Dow AgroSciences. Both companies have given the other rights to stack additional traits with their respective technology. Financial details of the agreement were not disclosed.

“This agreement gives us a new weed control option to help our customers meet their individual needs,” said Paul E. Schickler, president -- Pioneer. “Being able to offer farmers specific solutions to weed control is a key part of our Right Product, Right AcreSM strategy.”

Dow AgroSciences expects to submit herbicide-tolerant trait technology data to U.S. regulatory agencies this year. Dow AgroSciences anticipates commercialization early in the next decade pending regulatory authorizations.

“We are excited about the results of our investment in this next generation of technology in soybeans,” said Antonio Galindez, president and CEO -- Dow AgroSciences. “Our new herbicide-tolerant trait technology, in association with other leading weed control systems, offers growers the additional choices, unsurpassed flexibility, convenience and value that contribute to enhanced performance.”   

The new herbicide-tolerant trait technology allows growers to continue farming the way they want, but with improved weed control capabilities and performance. The system is designed to provide excellent control of glyphosate-resistant and other hard-to-control broadleaf weeds like morning glory, pigweeds including palmer amaranth, lambsquarters, marestail, waterhemp, giant and common ragweed, and velvetleaf. In anticipation of regulatory approvals for its herbicide-tolerant trait technology, Dow AgroSciences is developing new and improved herbicide solutions based on the proven, trusted 2,4-dichlorophenoxy acetic acid technology growers have used successfully for more than 60 years.

When stacked together, the Optimum® GAT® trait from Pioneer and the new herbicide-tolerant trait technology being developed by Dow AgroSciences would produce soybeans that are tolerant to 2,4-D, glyphosate and ALS herbicides. The Optimum® GAT® trait from Pioneer provides tolerance to glyphosate and the ALS class of herbicides. Optimum® GAT® soybeans have received U.S. regulatory approvals and a 2011 introduction is anticipated upon regulatory approvals in key importing countries. DuPont also anticipates the introduction of five new ALS-based herbicide products for Optimum® GAT® soybeans, including DuPont™ Freestyle™, Trigate™, Traverse™, Instigate™, and Diligent™ herbicides, upon U.S. and state approvals.

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element” to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Dow AgroSciences will market this technology in its soybean seed brands including Mycogen, Brodbeck, Dairyland, and Renze. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.

Pioneer Hi-Bred, a DuPont business, is the world’s leading source of customized solutions for farmers, livestock producers and grain and oilseed processors. With headquarters in Des Moines, Iowa, Pioneer provides access to advanced plant genetics in nearly 70 countries.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management’s current expectations, estimates and projections. The company does not undertake to update any forward-looking statements as a result of future developments or new information. All statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like “expects,” “anticipates,” “plans,” “intends,” “projects,” “indicates,” and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont’s filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.

DuPont
Doyle Karr
515-270-3428

Dow AgroSciences
Robyn Heine
317-337-4807

# # #

Read the full story at http://www.prweb.com/releases/DuPont_Dow/Pioneer_Hi-Bred/prweb3197354.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
2. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
3. Dow AgroSciences Success Presented to Wall Street
4. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
5. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
6. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
7. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
8. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
9. Dow AgroSciences Delivering Beyond Expectations
10. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
11. Dow AgroSciences Receives Approval for New Technology to Control Cotton Pests in Brazil
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DuPont, Dow AgroSciences Agree to Cross License Next-Generation Soybean Herbicide Tolerant Traits
(Date:2/4/2016)... Feb. 4, 2016  Spherix Incorporated (Nasdaq: SPEX ... and monetization of intellectual property, today provided an update ... the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings that ... The IPR was initiated on only certain claims of ...
(Date:2/3/2016)... 3, 2016   ViaCyte, Inc ., a ... pluripotent stem cell-derived islet replacement therapy for the ... today announced that ViaCyte and Janssen Biotech, Inc., ... & Johnson, have agreed to consolidate the assets ... agreement provides ViaCyte with an exclusive license to ...
(Date:2/3/2016)... NEW BRUNSWICK, N.J. , Feb. 3, 2016 ... 30 grants totaling more than $1 million for ... who are working on health-related research that demonstrates ... , this round of funding for the New ... available for faculty members at these educational institutions— ...
(Date:2/3/2016)... MEDFORD, Mass. , Feb. 3, 2016  Silk Therapeutics, ... A2 financing round. Silk Therapeutics has now raised a total ... progress made by the company. The Series A2 round was ... Foxboro, Massachusetts , with participation from new investors Lear ... Sheri and Roy P. Disney ; Richard Sackler ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/1/2016)... Feb. 1, 2016  Wocket® smart wallet ( www.wocketwallet.com ) announces the ... Joey Fatone . Las Vegas , where ... --> Las Vegas , where Joey appeared at ... The new video ad was filmed at the Consumer Electronics Show (CES2016) ... Wocket booth to meet and greet fans. --> ...
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
Breaking Biology News(10 mins):